| Risk factors for vancomycin nephrotoxicity and time course of renal function during vancomycin treatment T Hirai, K Hanada, A Kanno, M Akashi, T Itoh European Journal of Clinical Pharmacology 75, 859-866, 2019 | 28 | 2019 |
| Clinical predictors of nephrotoxicity associated with teicoplanin: Meta‐analysis and meta‐regression T Hirai, K Hosohata, Y Ogawa, T Iwamoto Basic & Clinical Pharmacology & Toxicology 130 (1), 110-121, 2022 | 11 | 2022 |
| Renin–angiotensin system inhibitors for countering proteinuria induced by angiogenesis inhibitors: a retrospective observational analysis T Hirai, Y Shuji, M Takiyama, K Hanada, T Itoh Cancer Chemotherapy and Pharmacology 84, 195-202, 2019 | 11 | 2019 |
| A retrospective study on the risk factors for bleeding events in warfarin therapy, focusing on renal function T Hirai, Y Hamada, Y Geka, S Kuwana, K Hirai, M Ishibashi, Y Fukaya, ... European Journal of Clinical Pharmacology 73, 1491-1497, 2017 | 9 | 2017 |
| Effect of high-dose sulfamethoxazole/trimethoprim and glucocorticoid use on hyperkalemic event: A retrospective observational study T Hirai, R Yamaga, Y Ishikawa, K Hanada, T Iwamoto, T Itoh Journal of Infection and Chemotherapy 27 (11), 1607-1613, 2021 | 7 | 2021 |
| Modeling and simulation for estimating the influence of renal dysfunction on the hypouricemic effect of febuxostat in hyperuricemic patients due to overproduction or … T Hirai, T Kimura, H Echizen Biological and Pharmaceutical Bulletin 39 (6), 1013-1021, 2016 | 7 | 2016 |
| Population pharmacokinetic analysis and dosage recommendations for digoxin in Japanese patients with atrial fibrillation and heart failure using real-world data T Hirai, H Kasai, M Naganuma, N Hagiwara, T Shiga BMC Pharmacology and Toxicology 23 (1), 14, 2022 | 6 | 2022 |
| Characteristics of risk factors for acute kidney injury among inpatients administered sulfamethoxazole/trimethoprim: a retrospective observational study Y Shimizu, T Hirai, Y Ogawa, C Yamada, E Kobayashi Journal of Pharmaceutical Health Care and Sciences 8 (1), 20, 2022 | 5 | 2022 |
| External Evaluation of a Bayesian Warfarin Dose Optimization Based on a Kinetic-Pharmacodynamic Model T Aoyama, T Hirai, Y Tsuji, A Miyamoto, T Itoh, T Iwamoto, Y Matsumoto Biological and Pharmaceutical Bulletin 45 (1), 136-142, 2022 | 5 | 2022 |
| Involvement of the effect of renal hypoperfusion medications on vancomycin trough concentration: A secondary analysis using a retrospective observational data T Hirai, K Hanada, T Iwamoto, T Itoh Basic & Clinical Pharmacology & Toxicology 129 (5), 376-384, 2021 | 5 | 2021 |
| Geriatric Patients Are at a High Risk of Hypokalemia Associated with Yokukansan Preparation: A Retrospective Cohort Study T Hirai, R Yamaga, M Kei, K Hosohata, T Itoh Biological and Pharmaceutical Bulletin 43 (11), 1742-1748, 2020 | 5 | 2020 |
| Drug-induced thrombotic microangiopathy using the Japanese pharmacovigilance database I Niinomi, K Hosohata, S Oyama, A Inada, T Hirai, K Iwanaga International Journal of Clinical Pharmacology and Therapeutics 58 (10), 543, 2020 | 5 | 2020 |
| Analysis of clinical factors in olaparib-related anemia using adverse drug event reporting databases C Shiraishi, T Hirai, T Ogura, T Iwamoto Anticancer Research 43 (2), 883-891, 2023 | 4 | 2023 |
| A meta-analysis of observational studies on anticholinergic burden and fracture risk: evaluation of conventional burden scales Y Ogawa, T Hirai, K Mihara Journal of Pharmaceutical Health Care and Sciences 7, 1-12, 2021 | 4 | 2021 |
| Safety profiles of new xanthine oxidase inhibitors: A post-marketing study T Wakabayashi, S Ueno, T Nakatsuji, T Hirai, I Niinomi, S Oyama, A Inada, ... International Journal of Clinical Pharmacology and Therapeutics 59 (5), 372, 2021 | 4 | 2021 |
| Low body mass index is a risk factor for hyperkalaemia associated with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers treatments T Hirai, R Yamaga, A Fujita, T Itoh Journal of Clinical Pharmacy and Therapeutics 43 (6), 829-835, 2018 | 4 | 2018 |
| Exploration of the optimal GS-441524 trough concentration for treating COVID-19 Y Nakano, Y Inokuchi, T Hayama, T Hirai, M Nishiyama, Y Sueyasu, ... International Journal of Antimicrobial Agents 62 (2), 106892, 2023 | 3 | 2023 |
| Drug-drug interaction between remdesivir and immunosuppressant agents in a kidney transplant recipient T Hirai, A Mizuta, T Sasaki, K Nishikawa, T Inoue, T Iwamoto International Journal of Clinical Pharmacology and Therapeutics 60 (10), 439, 2022 | 3 | 2022 |
| Relationship between recurrent falls and medication use during acute-care hospitalization: a retrospective descriptive study T Hirai, Y Ishikawa, Y Kawagoe, Y Ogawa, R Ogawa, T Itoh Biological and pharmaceutical bulletin 42 (7), 1192-1198, 2019 | 3 | 2019 |
| Pharmacokinetics of tacrolimus following an overdose in a patient with extreme obesity and genotype CYP3A5* 3/* 3: a case report T Hirai, Y Morikawa, N Sasaki, H Kato, D Nakato, M Hirayama, T Kaneko, ... The Journal of Toxicological Sciences 47 (2), 71-75, 2022 | 2 | 2022 |
Yuki NakanoDepartment of Pharmacy, Saiseikai Futsukaichi HospitalVerified email at saiseikai-futsukaichi.org
